Company Outline

Company Name Olympus Corporation
Established October 12, 1919
Representative Director, President and Chief Executive Officer Yasuo Takeuchi
Head Office Shinjuku Monolith, 3-1 Nishi-Shinjuku 2-chome, Shinjuku-ku, Tokyo 163-0914, Japan


Business Lines Manufacture and sales of precision machineries and instruments
Capital 124.56 billion yen (As of March 31, 2018)
Consolidated Net Sales 786.5 billion yen (Fiscal year ended March 31, 2018)
Consolidated Headcount 35,933 (As of March 31, 2018)

Share of Revenue by Business Segment (Unit: Billions of Yen)

Fiscal year ended March 2018: Total 786.5 billion Yen, Medical Systems 616.3 billion Yen (78.4%), Scientific Solutions 100.0 billion Yen (12.7%), Imaging 60.3 billion Yen (7.7%). Medical Systems Net Sales Breakdown: Endoscopes 336.8 billion Yen, Surgical Devices 200.4 billion Yen, Endo Therapy Devices 79.1 billion Yen.

The largest business segment is the medical systems, makes up nearly 80% of our revenue.

We deliver the diagnostic and therapeutic technologies such as gastrointestinal endoscopes, surgical endoscopy systems, and other peripherals, covering early diagnosis to minimally invasive therapy to provide the best possible outcomes for patients and society.

See Olympus Medical Business for details opens in new window

Number of Group Companies

Number of Group Companies: 98 (Excluding Olympus Corporation, and including nonconsolidated subsidiaries and equity-method affiliates.)

Revenue and Operating Profit

FY ended March 2014 (Revenue 713.3 billion Yen, operating profit 73.4 billion Yen), FY ended March 2015 (Revenue 764.7 billion Yen, operating profit 91.0 billion Yen), FY ended March 2016 (Revenue 804.6 billion Yen, operating profit 104.5 billion Yen), FY ended March 2017 (Revenue 740.6 billion Yen, operating profit 71.2 billion Yen), FY ended March 2018 (Revenue 786.5 billion Yen, operating profit 81.0 billion Yen)

Revenue by Region (Unit: Billions of Yen)

Fiscal year ended March 2018: Total 786.5 billion Yen, Japan 19.6%, North America 33.4%, Europe 24.3%, Asia and Oceania 20.4%, Other Region 2.4%.